0001562180-21-002904.txt : 20210421
0001562180-21-002904.hdr.sgml : 20210421
20210421211930
ACCESSION NUMBER: 0001562180-21-002904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210419
FILED AS OF DATE: 20210421
DATE AS OF CHANGE: 20210421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ford Alfred J Jr
CENTRAL INDEX KEY: 0001359446
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 21843013
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-04-19
false
0001603756
Axonics, Inc.
AXNX
0001359446
Ford Alfred J Jr
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
Chief Commercial Officer
Common Stock
2021-04-19
4
M
false
14871.00
1.42
A
28595.00
D
Common Stock
2021-04-19
4
M
false
5721.00
1.63
A
34316.00
D
Common Stock
2021-04-19
4
M
false
19258.00
14.19
A
53574.00
D
Common Stock
2021-04-19
4
M
false
6347.00
25.82
A
59921.00
D
Common Stock
2021-04-19
4
S
false
41794.00
58.3268
D
18127.00
D
Common Stock
2021-04-19
4
S
false
12502.00
59.3262
D
5625.00
D
Stock Option (Right to Buy)
25.82
2021-04-19
4
M
false
6347.00
0.00
D
2029-12-12
Common Stock
6347.00
13965.00
D
Stock Option (Right to Buy)
14.19
2021-04-19
4
M
false
19258.00
0.00
D
2029-01-30
Common Stock
19258.00
16297.00
D
Stock Option (Right to Buy)
1.63
2021-04-19
4
M
false
5721.00
0.00
D
2028-03-30
Common Stock
5721.00
1899.00
D
Stock Option (Right to Buy)
1.42
2021-04-19
4
M
false
14871.00
0.00
D
2027-11-15
Common Stock
14871.00
8509.00
D
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan
This transaction was executed in multiple trades at prices ranging from $57.87 to $58.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $58.87 to $59.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 12, 2023, provided the reporting person remains in continuous service on each vesting date.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on November 15, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of November 15, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
/s/ Dan Dearen, as Attorney-in-Fact for Alfred J. Ford, Jr.
2021-04-21